Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

180.26
Delayed Data
As of Mar 30
 -0.33 / -0.18%
Today’s Change
136.37
Today|||52-Week Range
203.30
-2.58%
Year-to-Date

Today’s Trading

Previous close180.59
Today’s open182.78
Day’s range178.31 - 183.73
Volume1,180,232
Average volume (3 months)1,287,791
Market cap$36.5B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+12.93%
Earnings growth (next 5 years)+21.19%
Revenue growth (last year)+46.49%
P/E ratio55.3
Price/Sales16.55
Price/Book10.89

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-1.63-2.64%
VRTXVertex Pharmaceutica...+0.91+0.76%
SHPGShire+1.01+0.42%
PRGOPerrigo Company PLC+2.29+1.38%
Data as of 03/30/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.32
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Treasurer
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account